超音波による血管閉塞予防法開発のための基礎的検討

「はじめに」急性脳梗塞 (acute ischemic stroke : AIS) 患者の治療法として, intravenous (IV) recombinant tissue-type plasminogen activator (rt-PA) が広く実施され著効を示している. 一方で, IV rt-PA療法により血流が再開通したにもかかわらず, 血栓が再成長するなどの理由より, IV rt-PA療法後24時間以内に14~34%の高確率で血管の再閉塞を発症してしまうという問題を抱えている. しかし, IV rt-PA療法後24時間以内に再閉塞予防を目的に抗血小板薬を投与すると, 症候性頭蓋内...

Full description

Saved in:
Bibliographic Details
Published inNeurosonology Vol. 30; no. 1; pp. 4 - 7
Main Authors 山本, 博之, 王, 作軍, 中田, 典生, 立花, 研, 澤口, 能一, 菊池, 蘭, 伊藤, 創馬, 中島, 孝則
Format Journal Article
LanguageJapanese
Published Kurashiki 一般社団法人日本脳神経超音波学会 01.01.2017
日本脳神経超音波学会
Japan Science and Technology Agency
Subjects
Online AccessGet full text
ISSN0917-074X
1884-3336
DOI10.2301/neurosonology.30.4

Cover

Abstract 「はじめに」急性脳梗塞 (acute ischemic stroke : AIS) 患者の治療法として, intravenous (IV) recombinant tissue-type plasminogen activator (rt-PA) が広く実施され著効を示している. 一方で, IV rt-PA療法により血流が再開通したにもかかわらず, 血栓が再成長するなどの理由より, IV rt-PA療法後24時間以内に14~34%の高確率で血管の再閉塞を発症してしまうという問題を抱えている. しかし, IV rt-PA療法後24時間以内に再閉塞予防を目的に抗血小板薬を投与すると, 症候性頭蓋内出血の頻度が顕著に高くなることが報告されており, 脳梗塞治療ガイドライン2015においても再閉塞予防を目的とした抗凝固薬などの薬剤の使用は認められていない. そのため, 一刻も早い新規血管再閉塞予防法の開発が望まれる.
AbstractList 「はじめに」急性脳梗塞 (acute ischemic stroke : AIS) 患者の治療法として, intravenous (IV) recombinant tissue-type plasminogen activator (rt-PA) が広く実施され著効を示している. 一方で, IV rt-PA療法により血流が再開通したにもかかわらず, 血栓が再成長するなどの理由より, IV rt-PA療法後24時間以内に14~34%の高確率で血管の再閉塞を発症してしまうという問題を抱えている. しかし, IV rt-PA療法後24時間以内に再閉塞予防を目的に抗血小板薬を投与すると, 症候性頭蓋内出血の頻度が顕著に高くなることが報告されており, 脳梗塞治療ガイドライン2015においても再閉塞予防を目的とした抗凝固薬などの薬剤の使用は認められていない. そのため, 一刻も早い新規血管再閉塞予防法の開発が望まれる.
Background: Reocclusion occurred after various recanalization therapies. In particular, reocclusion was frequently observed immediately after the recombinant tissue-type plasminogen activator (rt-PA) treatment. This is a fatal problem, because anticoagulant therapy is prohibited within 24 hours after the rt-PA treatment. We report the thrombus growth control effect of non-invasive ultrasound (US) in an in vitro clot growth model. Method: A clot was prepared by incubation of citrated human plasma, CaCl2 solution and thrombin at 37°C for 60 min in a latex tube. After incubation, the latex tube was filled with degassed citrated human plasma. The plasma around the clot was irradiated with US in a water bath at 37°C. The US irradiation condition was: transducer size 10 mm, frequency 500 kHz, continuous wave, average intensity 0.32 W/cm2, 30 min. To evaluate the thrombus growth control effect, the clot’s weight was measured before and after US irradiation. Results: The clot’s increased weight was significantly suppressed in the US group compared with the Non-US group (58.3 mg vs. 107.7 mg, p<0.0025). Conclusions: In this study, we showed that the non-invasive US could control the growth of thrombus. This safe and simple US method may be used to prevent the reocclusion after recanalization therapy.
Author 中島, 孝則
立花, 研
王, 作軍
中田, 典生
菊池, 蘭
山本, 博之
伊藤, 創馬
澤口, 能一
Author_xml – sequence: 1
  fullname: 山本, 博之
  organization: 日本薬科大学生命分子薬学分野
– sequence: 1
  fullname: 王, 作軍
  organization: 東京慈恵会医科大学超音波応用開発研究部
– sequence: 1
  fullname: 中田, 典生
  organization: 東京慈恵会医科大学超音波応用開発研究部
– sequence: 1
  fullname: 立花, 研
  organization: 日本薬科大学健康生命科学分野
– sequence: 1
  fullname: 澤口, 能一
  organization: 東京慈恵会医科大学超音波応用開発研究部
– sequence: 1
  fullname: 菊池, 蘭
  organization: 日本薬科大学臨床薬剤学分野
– sequence: 1
  fullname: 伊藤, 創馬
  organization: 日本薬科大学臨床薬剤学分野
– sequence: 1
  fullname: 中島, 孝則
  organization: 日本薬科大学臨床薬剤学分野
BookMark eNpVUE1Lw0AUXETBqv0DXj2nvt1NsslRSq1CwYuCt2WTbmtKTGrSHnqzRaFS8KaoiKXiQRB6sOChfyf261-4taJ4eDMP3jBvmDW0HISBRGgTQ4ZQwNuBrEdhHAahH5YbGQoZfQmlsGXpGqXUXEYpsDHTgOnHqygdx54DmJhg60BSaG_6cTnrDsaD56T5lrTaSasz7Z1P-r3Z7dWo9_Q5bM_u3seDm9ltZ3I_TJr9pNlNWk21jLrDycv15OFi_PI4fb3eQCsl4ccy_cPr6Gg3d5jd0woH-f3sTkGrqKhEw7buUuwy4ug2NjApUmIKIm3BhFMymCkM07IM1xCOIYoGFRYmQBzmALWLKrBL19HWwrcahWd1Gdd4JaxHgXrJsU1Mwgg2iFLlF6pTWfRc4YeB7wXyT-oG7Ls1TgAzDkABsCKiBvQ5sHlalUQ55RZOlbgmypJXI-9URA0uoprn-pL_K59T4HgO-u_dPRERrwj6BVMlmvM
ContentType Journal Article
Copyright 2017 日本脳神経超音波学会
Copyright Japan Science and Technology Agency 2017
Copyright_xml – notice: 2017 日本脳神経超音波学会
– notice: Copyright Japan Science and Technology Agency 2017
CorporateAuthor 日本薬科大学生命分子薬学分野
日本薬科大学健康生命科学分野
日本薬科大学臨床薬剤学分野
東京慈恵会医科大学超音波応用開発研究部
CorporateAuthor_xml – name: 東京慈恵会医科大学超音波応用開発研究部
– name: 日本薬科大学生命分子薬学分野
– name: 日本薬科大学臨床薬剤学分野
– name: 日本薬科大学健康生命科学分野
DOI 10.2301/neurosonology.30.4
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1884-3336
EndPage 7
ExternalDocumentID cn7neuro_2017_003001_002_0004_00073012885
article_neurosonology_30_1_30_4_article_char_ja
GroupedDBID .55
123
2WC
AL-
ALMA_UNASSIGNED_HOLDINGS
CS3
JMI
JSF
KQ8
MOJWN
OK1
RJT
X7M
ID FETCH-LOGICAL-j3012-194c31c72b491512d326a2e9a7abf576a56885c5ab5ad53a81202b7b039d402c3
ISSN 0917-074X
IngestDate Sat Sep 20 15:10:42 EDT 2025
Thu Jul 10 16:14:43 EDT 2025
Wed Sep 03 06:29:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j3012-194c31c72b491512d326a2e9a7abf576a56885c5ab5ad53a81202b7b039d402c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://www.jstage.jst.go.jp/article/neurosonology/30/1/30_4/_article/-char/ja
PQID 1926272152
PQPubID 2028960
PageCount 4
ParticipantIDs proquest_journals_1926272152
medicalonline_journals_cn7neuro_2017_003001_002_0004_00073012885
jstage_primary_article_neurosonology_30_1_30_4_article_char_ja
PublicationCentury 2000
PublicationDate 20170101
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 20170101
  day: 01
PublicationDecade 2010
PublicationPlace Kurashiki
PublicationPlace_xml – name: Kurashiki
PublicationTitle Neurosonology
PublicationTitleAlternate 神経超音波医学
PublicationYear 2017
Publisher 一般社団法人日本脳神経超音波学会
日本脳神経超音波学会
Japan Science and Technology Agency
Publisher_xml – name: 一般社団法人日本脳神経超音波学会
– name: 日本脳神経超音波学会
– name: Japan Science and Technology Agency
References 8)Barreto AD, Alexandrov AV, Lyden P, et al.: The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke 2012; 43: 770-775.
4)Alexandrov AV, Molina CA, Grotta JC, et al.: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178.
6)Azuma T, Kawabata K, Umemura S, et al.: Bubble Generation by Standing Wave in Water Surrounded by Cranium with Transcranial Ultrasonic Beam. Jpn J Appl Phys 2005; 44: 4625-4630.
2)Graham GD: Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003; 34: 2847-2850.
3)澤口能一,王作軍,古幡博: 超音波は血栓成長を抑制する―塞栓成長抑制・再閉塞予防の可能性―. J Med Ultrasonic 2011; 38: 549-555.
5)Daffertshofer M, Gass A, Ringleb P, et al.: Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke 2005; 36: 1441-1446.
1)Zinkstok SM, Roos YB, ARTIS investigators: Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet 2012; 380: 731-737.
7)Furuhata H, Saito O: Comparative study of standing wave reduction methods using random modulation for transcranial ultrasonication. Ultrasound Med Biol 2013; 39: 1440-1450.
References_xml – reference: 5)Daffertshofer M, Gass A, Ringleb P, et al.: Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke 2005; 36: 1441-1446.
– reference: 7)Furuhata H, Saito O: Comparative study of standing wave reduction methods using random modulation for transcranial ultrasonication. Ultrasound Med Biol 2013; 39: 1440-1450.
– reference: 6)Azuma T, Kawabata K, Umemura S, et al.: Bubble Generation by Standing Wave in Water Surrounded by Cranium with Transcranial Ultrasonic Beam. Jpn J Appl Phys 2005; 44: 4625-4630.
– reference: 1)Zinkstok SM, Roos YB, ARTIS investigators: Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet 2012; 380: 731-737.
– reference: 3)澤口能一,王作軍,古幡博: 超音波は血栓成長を抑制する―塞栓成長抑制・再閉塞予防の可能性―. J Med Ultrasonic 2011; 38: 549-555.
– reference: 2)Graham GD: Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003; 34: 2847-2850.
– reference: 4)Alexandrov AV, Molina CA, Grotta JC, et al.: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178.
– reference: 8)Barreto AD, Alexandrov AV, Lyden P, et al.: The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke 2012; 43: 770-775.
SSID ssib012609402
ssib005059357
ssib050594756
ssib004261862
ssib058494377
ssib000961632
ssib002004365
ssj0038460
Score 2.088729
Snippet 「はじめに」急性脳梗塞 (acute ischemic stroke : AIS) 患者の治療法として, intravenous (IV) recombinant tissue-type plasminogen activator (rt-PA) が広く実施され著...
Background: Reocclusion occurred after various recanalization therapies. In particular, reocclusion was frequently observed immediately after the recombinant...
SourceID proquest
medicalonline
jstage
SourceType Aggregation Database
Publisher
StartPage 4
SubjectTerms Blood clots
Blood plasma
Continuous radiation
In vitro methods and tests
Irradiation
Latex
non-invasive ultrasound
Occlusion
Plasma
Plasmas (physics)
prevention
reocclusion
rt-PA
Therapy
Thrombin
Title 超音波による血管閉塞予防法開発のための基礎的検討
URI https://www.jstage.jst.go.jp/article/neurosonology/30/1/30_4/_article/-char/ja
http://mol.medicalonline.jp/library/journal/download?GoodsID=cn7neuro/2017/003001/002&name=0004-0007j
https://www.proquest.com/docview/1926272152
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Neurosonology:神経超音波医学, 2017, Vol.30(1), pp.4-7
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1884-3336
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0038460
  issn: 0917-074X
  databaseCode: KQ8
  dateStart: 19880101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1NaxQxdCgVRBCpX1it0oM5Tt2ZSSbJRZzZnVKUCkILvQ2T2ZnDgqtoe_HkFoVKoTeLilgqPQhCDxY89O-s7Xb_he8lMztTK2IVlmw2eXl5H5nNe5nkxbJu85RKnkllSz9r21T4nq14ntm-VDlnuVK5g4eT5x_6c4v0_hJbGhufqO1aWllWM-mL354r-RetQhnoFU_JnkKzI6RQAHnQL6SgYUj_SsckEiT0iWAkkkTOktAjkY9p4JLIAyORBKHOuESIMhNiq8DBLQ4RJ0GEeWwOeCSJGP6UEYkoCQPdCqqgF7fALFkJHGJzKRGs6CsqMkBJ0ZdTq2KawkB3CgZspJtDFxQxQ4lsasIEVNUtZh09BJwCc6rGM-2ZJpGTkBHR_KMUNEAYasZaJBitQ2JB6OAHYKHroImDTcO3kCzkXwKTFTxHmoFrDQa1rYJiQC5aFRjUCOwKuYN8Y4SWYYUplbN1tKAjoxQRID0aHkobxNzLXK7JOPyXNZmiL9SjQE0BC0a2oZF2SAKvpjWtUJQ_8KtFOGIcm1MttlOKVktUY26CzOqrvkgsN5tiywmweDFWf9DNbEZrZhH_3XwL_ivOt936SJjxGjO0si5Gez6LpyQ-Bhx74INiQuOyHk8bxh1wec643PfxUpIHj2oeg_TBg6htBNB3KBxfERC1CJgMr6ysXuw74L5LWkW8w2pauwABzHFJPT5as_HAPNfLtKXczLk75PvOSa7Biu2AT4fBOs4_Nu9ZTbybE4aetl4XJqwLhds5HRjuL1pjneSSdXa-2Fhz2Zo7-v56uLV3uPe53_vaX13rr64fbb8c7G4PN98cbH_6sb82fPftcO_tcHN98H6_39vt97b6qz3IHGztD3Y2Bh9eHe58PPqyccVanI0WmnN2ccmK3QEmXNuRNPWclLuKSrT-2-DPJW4mE56onHE_Yb4QLGWJYkmbeQk4BA1XcdXwZBsEmXpXrfHuk252zZp2sgbNlMx5jpc6iFRmaZaqPKciVX6eO5PWXSOe-KmJpBOfckxMWveOiTUu_oufx2mXaxwxPo0Y7xisb_hycW8NjfV-BLTEBZu0pkpNVK0dDJrK8Ybv6_9L4g3rXPWHMGWNLz9byW6C27KsbumB_BPwtw8Q
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%B6%85%E9%9F%B3%E6%B3%A2%E3%81%AB%E3%82%88%E3%82%8B%E8%A1%80%E7%AE%A1%E9%96%89%E5%A1%9E%E4%BA%88%E9%98%B2%E6%B3%95%E9%96%8B%E7%99%BA%E3%81%AE%E3%81%9F%E3%82%81%E3%81%AE%E5%9F%BA%E7%A4%8E%E7%9A%84%E6%A4%9C%E8%A8%8E&rft.jtitle=Neurosonology%3A%E7%A5%9E%E7%B5%8C%E8%B6%85%E9%9F%B3%E6%B3%A2%E5%8C%BB%E5%AD%A6&rft.au=%E5%B1%B1%E6%9C%AC%2C+%E5%8D%9A%E4%B9%8B&rft.au=%E7%8E%8B%2C+%E4%BD%9C%E8%BB%8D&rft.au=%E4%B8%AD%E7%94%B0%2C+%E5%85%B8%E7%94%9F&rft.au=%E7%AB%8B%E8%8A%B1%2C+%E7%A0%94&rft.date=2017-01-01&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E6%97%A5%E6%9C%AC%E8%84%B3%E7%A5%9E%E7%B5%8C%E8%B6%85%E9%9F%B3%E6%B3%A2%E5%AD%A6%E4%BC%9A&rft.issn=0917-074X&rft.volume=30&rft.issue=1&rft.spage=4&rft.epage=7&rft_id=info:doi/10.2301%2Fneurosonology.30.4&rft.externalDocID=article_neurosonology_30_1_30_4_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0917-074X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0917-074X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0917-074X&client=summon